As the industry continues to shift to decentralized clinical trial (DCT) approaches, sponsors and CROs must now focus on how to make this change globally. This session will outline best practices learned over the past years in conducting global DCTs that should be considered to scale globally across complex regulatory landscapes.
Watch the video to learn:
- How to identify and plan the initial studies for DCT approaches to scale
- Understand how to evaluate country-specific regulatory requirements and feature specific limitations
- Assess DCT providers for optimal capabilities related to integrations, technical helpdesk, device provisioning and multi-lingual support availability
John Reites, CEO, THREAD